2007Chinese Journal of Clinical HepatologyRequires access

Study on the level of insulin-like growth factor-1 and its relationship with serum markers of hepatic fibrosis in chronic hepatitis B

Xian Yu

Open publisher page 2 citations

Abstract

To investigate the relationship of insulin-like growth factor-1(IGF-1) and its relationship with serum markers of hepatic fibrosis(HA、LN、PⅢP and Ⅳ.C) in chronic hepatitis B(CHB).The levels of serum IGF-1 and serum markers of hepatic fibrosis extracted from patients with CHB and liver cirrhosis were analyzed by RIA.Compared with the control,the level of serum markers of hepatic fibrosis was significantly higher in patients with CHB and liver cirrhosis.The level of serum IGF-1 in patients with CHB was significantly higher than that in control.While the level of serum IGF-1 in patients with liver cirrhosis was lower than that in control.There were positive relationship betweenthe levels of serum IGF-1 and serum markers of hepatic fibrosis in patients with CHB.And there was no relationship in patients with liver cirrhosis.IGF-1 might be related with liver damage and hepatic fibrosis in patients with CHB.

About this research paper

What this paper is about

To investigate the relationship of insulin-like growth factor-1(IGF-1) and its relationship with serum markers of hepatic fibrosis(HA、LN、PⅢP and Ⅳ.C) in chronic hepatitis B(CHB).The levels of serum IGF-1 and serum markers of hepatic fibrosis extracted from patients with CHB and liver cirrhosis were analyzed by RIA.Compared with the control,the level of serum markers of hepatic fibrosis was significantly higher in patients with CHB and liver cirrhosis.The level of serum IGF-1 in patients with CHB was significantly higher than that in control.While the level of serum IGF-1 in patients with liver cirrhosis was lower than that in control.There were positive relationship betweenthe levels of serum IGF-1 and serum markers of hepatic fibrosis in patients with CHB.And there was no relationship in patients with liver cirrhosis.IGF-1 might be related with liver damage and hepatic fibrosis in patients with CHB.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To investigate the relationship of insulin-like growth factor-1(IGF-1) and its relationship with serum markers of hepatic fibrosis(HA、LN、PⅢP and Ⅳ.C) in chronic hepatitis B(CHB).The levels of serum IGF-1 and serum markers of hepatic fibrosis extracted from patients with CHB and liver cirrhosis were analyzed by RIA.Compared with the control,the level of serum markers of hepatic fibrosis was significantly higher in patients with CHB and liver cirrhosis.The level of serum IGF-1 in patients with CHB was significantly higher than that in control.While the level of serum IGF-1 in patients with liver cirrhosis was lower than that in control.There were positive relationship betweenthe levels of serum IGF-1 and serum markers of hepatic fibrosis in patients with CHB.And there was no relationship in patients with liver cirrhosis.IGF-1 might be related with liver damage and hepatic fibrosis in patients with CHB.

Key concepts: Cirrhosis, Hepatic fibrosis, Internal medicine, Medicine, Fibrosis, Chronic hepatitis, Gastroenterology, Insulin-like growth factor

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on the level of insulin-like growth factor-1 and its relationship with serum markers of hepatic fibrosis in chronic hepatitis B — Research Paper | ScholarLens